Stroke, Vol 24, 1945-1950, Copyright © 1993 by American Heart Association
TJ Kilpatrick, Z Matkovic, SM Davis, CM McGrath and RJ Dauer
BACKGROUND AND PURPOSE: Primary hematologic abnormalities are a rare but
established cause of ischemic stroke. In addition, activation of hemostatic
parameters is often present during the acute phase of stroke. However, it
is uncertain whether these abnormalities occur in both cortical and lacunar
infarction; this study aimed to further assess this issue. METHODS:
Hematologic parameters (prothrombin, activated partial thromboplastin,
thrombin clotting, and euglobulin lysis times; and fibrinogen,
fibrinopeptide A, antithrombin III, protein C, protein S, and plasminogen
levels) were measured in 19 patients within 48 hours of the onset of acute
cerebral infarction. These patients included 10 with cortical infarcts and
9 with lacunar infarcts, as determined by standard clinical and
radiological criteria. RESULTS: Five patients with lacunar infarction and 7
patients with cortical infarction demonstrated raised fibrinopeptide A
levels, indicating enhanced thrombin activity. Fibrinolysis, assessed by
the euglobulin lysis time, was impaired in 6 of 9 patients with lacunar
infarction and in 2 of 10 patients with cortical infarction. Lupus
anticoagulants were detected in 3 patients with lacunar infarction and in 1
patient with cortical infarction. Three patients in each group displayed
decreased antithrombin III function, and 1 patient with a lacunar
infarction had a low protein C level. CONCLUSIONS: Primary hematologic
disorders and secondary hemostatic derangements may occur in patients with
either cortical or lacunar infarction.
ARTICLES
Hematologic abnormalities occur in both cortical and lacunar infarction
Department of Neurology, Royal Melbourne Hospital, Victoria, Australia.
This article has been cited by other articles:
![]() |
J. Jannes, M. A. Hamilton-Bruce, L. Pilotto, B. J. Smith, C. G. Mullighan, P. G. Bardy, and S. A. Koblar Tissue Plasminogen Activator -7351C/T Enhancer Polymorphism Is a Risk Factor for Lacunar Stroke Stroke, May 1, 2004; 35(5): 1090 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tomimoto, I. Akiguchi, H. Wakita, A. Osaki, M. Hayashi, and Y. Yamamoto Coagulation Activation in Patients With Binswanger Disease Arch Neurol, September 1, 1999; 56(9): 1104 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Longstreth Jr, C. Bernick, T. A. Manolio, N. Bryan, C. A. Jungreis, T. R. Price, and for the Cardiovascular Health Study Collaborative Lacunar Infarcts Defined by Magnetic Resonance Imaging of 3660 Elderly People: The Cardiovascular Health Study Arch Neurol, September 1, 1998; 55(9): 1217 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roden-Jullig, M. Britton, and J. Svensson Antithrombin-III Activity and the Efficacy of Heparin in Progressing Ischemic Stroke Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 129 - 132. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |